The risk of recurrence is approximately 40 50 % and lifelong treatment with antithyroid drugs carries some side effects such as agranulocytosis and liver disease.
5.
These two markers are a positive specificity 98 % ), a negative TSHR-Ab at the end of antithyroid drug treatment is associated with a 78 % chance of remaining in remission.
6.
These two markers are an elevated level of specificity 98 % ), a negative TSHR-Ab at the end of antithyroid drug treatment is associated with a 78 % chance of remaining in remission.
7.
Therapy with radioiodine is the most common treatment in the United States, while antithyroid drugs and / or thyroidectomy are used more often in Europe, Japan, and most of the rest of the world.
8.
For an overactive thyroid, which produces too much hormone, there are three options : radioactive iodine, a one-time oral treatment that destroys the gland; antithyroid drugs, which have a success rate of 1 out of 3; or surgery to remove the gland.